Qin Yue

Catabolic Fate and Pharmacokinetic Characterization of Trastuzumab Emtansine (T-DM1): an Emphasis on Preclinical and Clinical Catabolism

Ben‐Quan Shen, Daniela Bumbaca, Ola M. Saad et al. · Current Drug Metabolism · 2012 · 135 citations

Oncology, Trastuzumab Emtansine, Clinical Catabolism +13

Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase

Peter S. Dragovich, Benjamin P. Fauber, Laura Corson et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 90 citations · Full text

Aldehyde Dehydrogenase, Human Lactate Dehydrogenase, Biochemistry +6

Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition

Brian S. Safina, Stewart Baker, Matt Baumgardner et al. · Journal of Medicinal Chemistry · 2012 · 66 citations · Full text

Drug Target, Immunology, Inflammatory Arthritis +25

Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase

Benjamin P. Fauber, Peter S. Dragovich, Jinhua Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 60 citations · Full text

Medicinal Chemistry, Biochemistry, Human Lactate Dehydrogenase +6

A Single Dose Mass Balance Study of the Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Humans Using Accelerator Mass Spectrometry

Richard Graham, Bert L. Lum, Glenn Morrison et al. · Drug Metabolism and Disposition · 2011 · 56 citations